★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★

Checking

Stock Profile

Straumann Holding AG (STMN) Moat Analysis

Straumann Holding AG

STMN · SIX Swiss Exchange

Market cap (USD)$18.5B
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryCH
Data as of
Moat score
37/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Request update

Spot something outdated? Send a quick note and source so we can refresh this profile.

Overview

Straumann is a dental-technology group focused on implantology, orthodontics and digital workflows. Implantology has the clearest moat: company-estimated 2025 global share above 35%, trusted premium brands and large-scale clinician education, although multi-system use limits training-related switching costs. Orthodontics is verified moatless at company-estimated share below 5%; outsourcing to Smartee improves costs but is not proprietary. Digital retains only a weak complements moat around the AXS scanner-software-services-consumables workflow; open architecture supports adoption rather than lock-in, and category retention and margins are undisclosed. Audited 2025 IFRS margins are 68.58% gross, 21.08% operating and 13.71% net, correcting overstated stored values. Product-line revenue shares are omitted because audited reporting uses geographic operating segments and does not disaggregate these three analytical franchises.

Primary segment

Implantology (Tooth Replacement & Restoration)

Market structure

Oligopoly

Market share

HHI:

Coverage

3 segments · 7 tags

Updated 2026-08-23

Segments

Implantology (Tooth Replacement & Restoration)

Dental implantology (tooth replacement and restoration solutions)

Revenue

Structure

Oligopoly

Pricing

moderate

Share

Peers

NVSTXRAYZBHHSIC

Orthodontics (Clear Aligner Solutions)

Clear aligner orthodontics (treatment planning + aligner manufacturing)

Revenue

Structure

Oligopoly

Pricing

weak

Share

Peers

ALGNNVSTXRAY

Digital Dentistry & Prosthetics Workflow

Digital dentistry workflows (intraoral scanners, cloud platforms, CAD/CAM and chairside prosthetic production)

Revenue

Structure

Competitive

Pricing

weak

Share

Peers

XRAYALGNDDDSSYS

Moat Claims

Implantology (Tooth Replacement & Restoration)

Dental implantology (tooth replacement and restoration solutions)

Oligopoly

Brand Trust

Demand

Strength

Strength 4 of 5

Durability

Durability 3 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 2 of 5

Company-estimated implantology share above 35%, premium-brand demand and more than one million iEXCEL implants sold support clinician trust; tender pressure and capable premium peers keep the score below maximum.

Brand Trust moat: definition, examples, and stocks

Erosion risks

  • Price controls / tenders (e.g., China VBP) compress premium pricing
  • Feature/clinical evidence parity from competitors
  • Brand damage from quality or safety issues

Leading indicators

  • Implantology market share trend
  • Premium mix (share of premium SKUs within implant sales)
  • New product adoption (e.g., flagship implant system volumes)

Counterarguments

  • Competitors have comparable clinical evidence and premium brands, limiting differentiation
  • Patients and clinics may trade down in price-sensitive markets

Training Org Change Costs

Demand

Strength

Strength 3 of 5

Durability

Durability 3 of 3

Confidence

Confidence 3 of 5

Evidence

Evidence 2 of 5

Education at exceptional scale reinforces system-specific clinical familiarity and account conversion, but the company does not quantify switching cost and clinicians can maintain multiple implant systems.

Training Org Change Costs moat: definition, examples, and stocks

Erosion risks

  • Standardized surgical workflows reduce brand-specific training needs
  • DSOs standardize purchasing across brands based on price
  • Increased use of guided surgery and digital planning reduces procedural variability

Leading indicators

  • Training/course participation and certification counts
  • Rep/clinical support coverage and engagement
  • Clinic share-of-wallet and repeat ordering behavior

Counterarguments

  • Clinicians can multi-source implants; retraining costs may be manageable
  • Digital planning and standard kits can make switching easier over time

Orthodontics (Clear Aligner Solutions)

Clear aligner orthodontics (treatment planning + aligner manufacturing)

The Q1 2026 presentation reports 2025 clear-aligner share below 5%, without a lower bound. Smartee now provides EMEA/APAC manufacturing and DentalMonitoring supports remote workflows; these partnerships improve cost and service but do not establish proprietary lock-in.

Oligopoly

Digital Dentistry & Prosthetics Workflow

Digital dentistry workflows (intraoral scanners, cloud platforms, CAD/CAM and chairside prosthetic production)

Q1 2026 AXS users grew more than 50% over six months and management cited recurring digital-services and consumables growth. Open architecture is an adoption feature, not a separate interoperability barrier; active-user totals, retention, attach rates and category economics remain undisclosed.

Competitive

Ecosystem Complements

Network

Strength

Strength 2 of 5

Durability

Durability 2 of 3

Confidence

Confidence 3 of 5

Evidence

Evidence 2 of 5

AXS links scanners, software, chairside production, services and consumables, creating cross-sell and recurring-revenue potential. Its open architecture, undisclosed retention and attach rates, and comparable rival workflows limit this to a weak moat.

Ecosystem Complements moat: definition, examples, and stocks

Erosion risks

  • Hardware commoditization (scanners/printers) reduces differentiation
  • Dental labs may resist vendor lock-in and demand open formats
  • Competitors bundle at lower price points

Leading indicators

  • Scanner installs and utilization
  • Cross-sell rates (scanner -> software -> production/consumables)
  • Renewal rates for software/services

Counterarguments

  • Clinics can assemble similar workflows from multiple vendors
  • Bundling can face pushback if any component is inferior to best-in-class alternatives

Evidence

other

strong demand for our premium and challenger implant brands

Official annual report commentary supports durable clinician demand for the implant portfolio.

other

With more than one million implants sold

High adoption of the flagship implant system indicates clinical trust and commercial pull.

other

over 10 700 educational activities and trained more than 370 000 doctors

Large education footprint supports clinician familiarity and process inertia.

other

further strengthening its leadership through education and clinical engagement

Shows education remains a current strategic lever for implantology share and clinician retention.

other

fully integrated into the Straumann AXS workflow

Direct evidence of a complements-based system (hardware+software+production) reinforcing adoption.

Showing 5 of 6 sources.

Risks & Indicators

Erosion risks

  • Price controls / tenders (e.g., China VBP) compress premium pricing
  • Feature/clinical evidence parity from competitors
  • Brand damage from quality or safety issues
  • Standardized surgical workflows reduce brand-specific training needs
  • DSOs standardize purchasing across brands based on price
  • Increased use of guided surgery and digital planning reduces procedural variability

Leading indicators

  • Implantology market share trend
  • Premium mix (share of premium SKUs within implant sales)
  • New product adoption (e.g., flagship implant system volumes)
  • Training/course participation and certification counts
  • Rep/clinical support coverage and engagement
  • Clinic share-of-wallet and repeat ordering behavior

Keep the research going

Created 2026-01-10
Updated 2026-08-23

More Rankings & Systems

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.